Radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma

World J Gastrointest Oncol. 2021 Oct 15;13(10):1453-1465. doi: 10.4251/wjgo.v13.i10.1453.

Abstract

Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is a rare disease which is often associated with Helicobacter pylori (H. pylori) infection. First-line treatment of stage IE and IIE localized gastric MALT lymphoma is based on the eradication of H. pylori. The presence of H. pylori resistance factors such as translocation t (11;18), peri-gastric lymph node involvement and the degree of tumor infiltration of the gastric wall; or lack of response to antibiotic therapy are two main indications to treat with definitive radiotherapy (RT). RT is an effective treatment in localized gastric MALT lymphoma. A moderate dose of 30 Gy allows a high cure rate while being well tolerated. After treatment, regular gastric endoscopic follow-up is necessary to detect a potential occurrence of gastric adenocarcinoma.

Keywords: Helicobacter pylori; Lymphoma; MALT; Mucosa-associated lymphoid tissue; Radiotherapy; Review.

Publication types

  • Review